1. Home
  2. QNCX vs OSS Comparison

QNCX vs OSS Comparison

Compare QNCX & OSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • OSS
  • Stock Information
  • Founded
  • QNCX 2012
  • OSS 1998
  • Country
  • QNCX United States
  • OSS United States
  • Employees
  • QNCX N/A
  • OSS N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • OSS Computer Manufacturing
  • Sector
  • QNCX Health Care
  • OSS Technology
  • Exchange
  • QNCX Nasdaq
  • OSS Nasdaq
  • Market Cap
  • QNCX 44.0M
  • OSS 62.7M
  • IPO Year
  • QNCX 2019
  • OSS 2018
  • Fundamental
  • Price
  • QNCX $1.02
  • OSS $2.21
  • Analyst Decision
  • QNCX Strong Buy
  • OSS
  • Analyst Count
  • QNCX 5
  • OSS 0
  • Target Price
  • QNCX $8.00
  • OSS N/A
  • AVG Volume (30 Days)
  • QNCX 138.1K
  • OSS 154.8K
  • Earning Date
  • QNCX 05-12-2025
  • OSS 05-08-2025
  • Dividend Yield
  • QNCX N/A
  • OSS N/A
  • EPS Growth
  • QNCX N/A
  • OSS N/A
  • EPS
  • QNCX N/A
  • OSS N/A
  • Revenue
  • QNCX N/A
  • OSS $54,694,359.00
  • Revenue This Year
  • QNCX N/A
  • OSS $9.65
  • Revenue Next Year
  • QNCX N/A
  • OSS $11.43
  • P/E Ratio
  • QNCX N/A
  • OSS N/A
  • Revenue Growth
  • QNCX N/A
  • OSS N/A
  • 52 Week Low
  • QNCX $0.51
  • OSS $1.82
  • 52 Week High
  • QNCX $2.45
  • OSS $4.88
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 26.91
  • OSS 41.42
  • Support Level
  • QNCX $0.93
  • OSS $1.98
  • Resistance Level
  • QNCX $1.26
  • OSS $2.27
  • Average True Range (ATR)
  • QNCX 0.10
  • OSS 0.22
  • MACD
  • QNCX -0.03
  • OSS 0.01
  • Stochastic Oscillator
  • QNCX 18.03
  • OSS 42.35

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bresssner segment.

Share on Social Networks: